ArticleJournal of pharmaceutical analysis2023

Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease.

Chang Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.